Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -3.94% | 74.67 | 1.0% | $1808.50m | |
| AMGN | Amgen, Inc. | -1.32% | 208.78 | 1.3% | $898.33m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.55% | 501.51 | 2.6% | $832.58m | |
| BIIB | Biogen, Inc. | -3.27% | 301.21 | 1.5% | $768.55m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.99% | 247.67 | 1.9% | $644.24m | |
| MRNA | Moderna, Inc. | -7.56% | 32.02 | 0.0% | $518.77m | |
| ILMN | Illumina, Inc. | 0.95% | 280.64 | 3.5% | $494.32m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.24% | 94.72 | 2.0% | $299.75m | |
| A | Agilent Technologies, Inc. | -0.46% | 74.02 | 1.6% | $226.92m | |
| INCY | Incyte Corp. | 1.82% | 86.66 | 2.5% | $218.22m | |
| EXAS | EXACT Sciences Corp. | 0.53% | 62.60 | 21.0% | $178.66m | |
| SGEN | Seattle Genetics, Inc. | -2.09% | 121.87 | 6.1% | $164.60m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -3.55% | 79.83 | 4.3% | $153.92m | |
| IMMU | Immunomedics, Inc. | 0.69% | 18.91 | 11.9% | $120.80m | |
| NVAX | Novavax, Inc. | -7.45% | 14.90 | 114.7% | $113.95m |
Company Profile
Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.